IPO registrations (S-1, F-1) · Registrants
HCW Biologics Inc.
- SEC CIK
- 1828673 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2021-05-26, last 2026-10-02; 9 initial registrations, 9 amendments
- Outcome
- Final prospectus filed 2021-07-21; declared effective 2021-07-19
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 2929 N COMMERCE PKWY, Miramar, FL 33025
- EIN
- 82-5024477
- Ticker
- HCWB (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- HCW Biologics Inc. on the corporate pages
Offering terms
- Proposed price range
- $8.00–$10.00 per share (S-1/A filed 2021-07-09)
- Final price
- $8.00 per share, within the range (424B4 filed 2021-07-21, an initial public offering)
- Shares sold
- 7,000,000
- Gross proceeds
- $56,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol HCWB
- Lead underwriters
- EF Hutton; The Benchmark Company
- Syndicate
- Revere Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: HCW THERAPEUTICS INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: HCW BIOLOGICS, LLC Fuzzy (name and state)
- Form 5500 plan sponsor: HCW BIOLOGICS, INC. EXACT (EIN (EXACT))
- Form D issuer: HCW Biologics Inc. EXACT (CIK (EXACT))
- SEC filer: HCW Biologics Inc. EXACT (CIK (EXACT))
- Person page: Lisa M Giles Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 32
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-05-26 | S-1 | S-1 (registration) | HCW Biologics Inc. | 0001193125-21-173753 ↗ |
| 2021-06-15 | S-1/A | S-1/A (amendment) | HCW Biologics Inc. | 0001193125-21-191316 ↗ |
| 2021-07-07 | S-1/A | S-1/A (amendment) | HCW Biologics Inc. | 0001193125-21-209000 ↗ |
| 2021-07-09 | S-1/A | S-1/A (amendment) | HCW Biologics Inc. | 0001193125-21-212005 ↗ |
| 2021-07-19 | S-1MEF | S-1MEF (added securities) | HCW Biologics Inc. | 0001193125-21-218757 ↗ |
| 2021-07-19 | EFFECT | EFFECT (declared effective) | HCW Biologics Inc. | 9999999995-21-002826 ↗ |
| 2021-07-21 | 424B4 | 424B4 (final prospectus) | HCW Biologics Inc. | 0001193125-21-220633 ↗ |
| 2022-08-26 | EFFECT | EFFECT (declared effective) | HCW Biologics Inc. | 9999999995-22-002524 ↗ |
| 2025-04-07 | S-1 | S-1 (registration) | HCW Biologics Inc. | 0001193125-25-073723 ↗ |
| 2025-04-16 | EFFECT | EFFECT (declared effective) | HCW Biologics Inc. | 9999999995-25-001134 ↗ |
| 2025-05-09 | S-1 | S-1 (registration) | HCW Biologics Inc. | 0001193125-25-116745 ↗ |
| 2025-05-13 | S-1/A | S-1/A (amendment) | HCW Biologics Inc. | 0001193125-25-118837 ↗ |
| 2025-05-13 | EFFECT | EFFECT (declared effective) | HCW Biologics Inc. | 9999999995-25-001610 ↗ |
| 2025-05-15 | 424B4 | 424B4 (final prospectus) | HCW Biologics Inc. | 0001193125-25-120468 ↗ |
| 2026-01-09 | S-1 | S-1 (registration) | HCW Biologics Inc. | 0001193125-26-009044 ↗ |
| 2026-01-29 | EFFECT | EFFECT (declared effective) | HCW Biologics Inc. | 9999999995-26-000348 ↗ |
| 2026-02-11 | S-1 | S-1 (registration) | HCW Biologics Inc. | 0001193125-26-046873 ↗ |
| 2026-02-13 | S-1/A | S-1/A (amendment) | HCW Biologics Inc. | 0001193125-26-051317 ↗ |
| 2026-02-17 | S-1/A | S-1/A (amendment) | HCW Biologics Inc. | 0001193125-26-053303 ↗ |
| 2026-02-17 | EFFECT | EFFECT (declared effective) | HCW Biologics Inc. | 9999999995-26-000619 ↗ |
| 2026-02-19 | 424B4 | 424B4 (final prospectus) | HCW Biologics Inc. | 0001193125-26-059279 ↗ |
| 2026-04-23 | S-1 | S-1 (registration) | HCW Biologics Inc. | 0001493152-26-018758 ↗ |
| 2026-04-24 | S-1/A | S-1/A (amendment) | HCW Biologics Inc. | 0001493152-26-018992 ↗ |
| 2026-04-29 | EFFECT | EFFECT (declared effective) | HCW Biologics Inc. | 9999999995-26-001391 ↗ |
| 2026-06-08 | S-1 | S-1 (registration) | HCW Biologics Inc. | 0001493152-26-027656 ↗ |
| 2026-06-18 | S-1/A | S-1/A (amendment) | HCW Biologics Inc. | 0001493152-26-029235 ↗ |
| 2026-06-18 | EFFECT | EFFECT (declared effective) | HCW Biologics Inc. | 9999999995-26-002066 ↗ |
| 2026-08-20 | S-1 | S-1 (registration) | HCW Biologics Inc. | 0001493152-26-039452 ↗ |
| 2026-08-28 | S-1/A | S-1/A (amendment) | HCW Biologics Inc. | 0001493152-26-040618 ↗ |
| 2026-08-31 | EFFECT | EFFECT (declared effective) | HCW Biologics Inc. | 9999999995-26-002836 ↗ |
| 2026-10-02 | S-1 | S-1 (registration) | HCW Biologics Inc. | 0001493152-26-045532 ↗ |
| 2026-10-09 | EFFECT | EFFECT (declared effective) | HCW Biologics Inc. | 9999999995-26-003211 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-09 | S-1/A | registration statement | $8.00–$10.00 | $9.00 | 5,600,000 | $50,400,000 | Nasdaq HCWB | 2 | primary document; range, price sentence, shares headline, proceeds computed, cover names 2 | document ↗ |
| 2021-07-21 | 424B4 | final prospectus | $8.00 | 7,000,000 | $56,000,000 | Nasdaq HCWB | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Byam Rebecca | Officer | Chief Financial Officer | 26 | 2021–2026 | |
| Flowers Lee | Officer | SVP of Business Development | 12 | 2021–2026 | |
| GARRETT SCOTT T | Director | 11 | 2021–2026 | ||
| Greene Rick S. | Director | 8 | 2021–2025 | ||
| Jiao Jin-an | Officer | VP of Development | 4 | 2021–2022 | |
| Medmira Capital Ltd. | TenPercentOwner | 3 | 2021 | ||
| Rhode Peter | Officer | See Remarks | 6 | 2021–2023 | |
| Wong Hing C | Director,Officer; Director,Officer,TenPercentOwner | Chief Executive Officer | 19 | 2021–2026 | |
| Giles Lisa M. | Director | 6 | 2021–2024 | person page Fuzzy | |
| Winer Gary M | Director | 14 | 2021–2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-08-06 | HCW Biologics Inc. | Biotechnology | $1,600,000 | $1,600,000 | 4 | 1 |
| 2026-06-08 | HCW Biologics Inc. | Biotechnology | $4,000,000 | $4,000,000 | 7 | 1 |
| 2024-12-05 | HCW Biologics Inc. | Biotechnology | $6,918,254 | $6,918,254 | 1 | 1 |
| 2024-02-27 | HCW Biologics Inc. | Biotechnology | $2,500,005 | $2,500,005 | 6 | 1 |
| 2020-10-19 | HCW Biologics Inc. | Biotechnology | $16,000,000 | $6,168,320 | 9 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | HCW BIOLOGICS, LLC | FL | State business registries | name and state |
| Plan sponsor | HCW BIOLOGICS, INC | FL | Form 5500 (employee benefit plans) | name and state |
| Plan sponsor | HCW BIOLOGICS, INC. | FL | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | HCW Biologics Inc. | FL | Form D private offerings | CIK (EXACT) |
| Patent assignee | HCW Biologics, Inc. | FL | Patents (USPTO) | name and state |
| SEC filer | HCW Biologics Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | HCW Biologics Inc. | FL | Trademarks (USPTO) | name and state |
| Business registration | HCW THERAPEUTICS INC. | State business registries | EIN (EXACT, as the state registration reports it) | |
| Form 5500 plan sponsor | HCW BIOLOGICS, INC. | EIN (EXACT) | ||
| Person page | Lisa M Giles | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, FL first:
- SANO CORP FL
- CTT PHARMACEUTICAL HOLDINGS, INC. FL
- Inhibitor Therapeutics, Inc. FL
- GENEREX BIOTECHNOLOGY CORP FL
- BIOMOLECULAR LIFE HOLDINGS, INC. FL
- Alaunos Therapeutics, Inc. FL
- ORAGENICS INC FL
- Polomar Health Services, Inc. FL
- ACCENTIA BIOPHARMACEUTICALS INC FL
- NOMAD POWER SOLUTIONS, INC. FL
In other datasets, the same topic (Health) in FL:
- Nonprofit: 414 WELLWOMEN INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health